New cancer clinical trial: Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Published on: December 18, 2020 at 12:00PM
Conditions:   Stage IIA Triple Negative Breast Cancer;   Triple Negative Breast Cancer
Interventions:   Biological: α-lactalbumin vaccine;   Biological: Zymosan
Sponsor:   George T. Budd
Not yet recruiting
https://ift.tt/2WxD1jG